Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
FOLITIXORIN
ID: ALA117348
Max Phase: Phase
Molecular Formula: C20H23N7O6
Molecular Weight: 457.45
Molecule Type: Small molecule
Associated Items:
ID: ALA117348
Max Phase: Phase
Molecular Formula: C20H23N7O6
Molecular Weight: 457.45
Molecule Type: Small molecule
Associated Items:
Synonyms (2): 5,10-methylenetetrafolate | Folitixorin
Synonyms from Alternative Forms(2):
Canonical SMILES: Nc1nc(=O)c2c([nH]1)NCC1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)CN21
Standard InChI: InChI=1S/C20H23N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,12-13H,5-9H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31)/t12?,13-/m0/s1
Standard InChI Key: QYNUQALWYRSVHF-ABLWVSNPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.45 | Molecular Weight (Monoisotopic): 457.1710 | AlogP: -0.52 | #Rotatable Bonds: 7 |
Polar Surface Area: 193.98 | Molecular Species: ACID | HBA: 9 | HBD: 6 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.24 | CX Basic pKa: 5.29 | CX LogP: -2.17 | CX LogD: -7.13 |
Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.31 | Np Likeness Score: -0.06 |
1. Erlanson DA, McDowell RS, O'Brien T.. (2004) Fragment-based drug discovery., 47 (14): [PMID:15214773] [10.1021/jm040031v] |
2. Kusuhara H, Han YH, Shimoda M, Kokue E, Suzuki H, Sugiyama Y.. (1998) Reduced folate derivatives are endogenous substrates for cMOAT in rats., 275 (1): [PMID:9756510] [10.1152/ajpgi.1998.275.4.g789] |
3. Kisliuk RL, Strumpf D, Gaumont Y, Leary RP, Plante L.. (1977) Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid., 20 (11): [PMID:410932] [10.1021/jm00221a038] |
4. Kisliuk RL, Strumpf D, Gaumont Y, Leary RP, Plante L.. (1977) Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid., 20 (11): [PMID:410932] [10.1021/jm00221a038] |
5. Kisliuk RL, Strumpf D, Gaumont Y, Leary RP, Plante L.. (1977) Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid., 20 (11): [PMID:410932] [10.1021/jm00221a038] |
Source(2):